
Reversal of fortune – Full Court decides that an artificial intelligence is not an “inventor”
Anthony Selleck reviews the decision in Commissioner of Patents v Thaler [2022] FCAFC 62 which reverses an earlier ruling that artificial intelligence can be an “inventor” for the purposes of the Australian Patents Act 1990.
Read more

Federal Budget 2022: What’s in it to accelerate Australia’s innovation agenda?
We discuss the key measures in Australia’s 2022-23 federal budget that could help drive innovation, research commercialisation and business growth.
Read more

Saving grace: Options if you disclose your invention without a patent application
Publicly disclosing new technology before a patent application has been filed can jeopardise patent coverage – but there are options available to you in the event of disclosure.
Read more

Virus filtration patent gets clean bill of health
In a recent decision of the Australian Patent Office, a patent application directed to a membrane for filtering biological products was upheld following opposition.
Read more

Draft roadmap for Australian regenerative medicine released for comment
AusBiotech has released a draft strategic roadmap for a new regenerative medicine Catalyst.
Read more

Australian government rediscovers R&D value amid COVID-19 crisis
Prior to COVID-19, Australia enjoyed an enviable economic record; outperforming much of the world and avoiding recession for 29 years.
Read more

Thirteen – unlucky for some: Support and sufficiency in Australia following MSD v Wyeth
The MSD v Wyeth judgment demonstrates the more exacting standard now required for the level of disclosure in patent specifications. It also cements the shift in Australia towards alignment with UK and European requirements.
Read more